-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CKD-846 in Benign Prostatic Hyperplasia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CKD-846 in Benign Prostatic Hyperplasia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CKD-846 in Benign Prostatic Hyperplasia Drug Details: CKD-846 is under development...
-
Product Insights
Angina (Angina Pectoris) – Drugs In Development, 2023
Global Markets Direct’s, ‘Angina (Angina Pectoris) - Drugs In Development, 2023’, provides an overview of the Angina (Angina Pectoris) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Angina (Angina Pectoris), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Uremic (Renal) Pruritus – Drugs In Development, 2023
Global Markets Direct’s, ‘Uremic (Renal) Pruritus - Drugs In Development, 2023’, provides an overview of the Uremic (Renal) Pruritus pipeline landscape. The report provides comprehensive information on the therapeutics under development for Uremic (Renal) Pruritus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Male Hypogonadism – Drugs In Development, 2023
Global Markets Direct’s, ‘Male Hypogonadism - Drugs In Development, 2023’, provides an overview of the Male Hypogonadism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Male Hypogonadism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Menopausal Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Menopausal Disorders - Drugs In Development, 2023’, provides an overview of the Menopausal Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Menopausal Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Benign Prostatic Hyperplasia – Drugs In Development, 2023
Global Markets Direct’s, ‘Benign Prostatic Hyperplasia - Drugs In Development, 2023’, provides an overview of the Benign Prostatic Hyperplasia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Benign Prostatic Hyperplasia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Idiopathic (Essential) Hypertension – Drugs In Development, 2023
Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Drugs In Development, 2023’, provides an overview of the Idiopathic (Essential) Hypertension pipeline landscape. The report provides comprehensive information on the therapeutics under development for Idiopathic (Essential) Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Ocular Hypertension – Drugs In Development, 2023
Global Markets Direct’s, ‘Ocular Hypertension - Drugs In Development, 2023’, provides an overview of the Ocular Hypertension pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ocular Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Reflux Esophagitis (Gastroesophageal Reflux Disease) – Drugs In Development, 2023
Global Markets Direct’s, ‘Reflux Esophagitis (Gastroesophageal Reflux Disease) - Drugs In Development, 2023’, provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Reflux Esophagitis (Gastroesophageal Reflux Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Androgenic Alopecia – Drugs In Development, 2023
Global Markets Direct’s, ‘Androgenic Alopecia - Drugs In Development, 2023’, provides an overview of the Androgenic Alopecia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Androgenic Alopecia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...